1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antisense and RNAi Therapeutics Market Size Growth Rate by Type (2020-2025)
1.3.2 RNA Interference
1.3.3 Antisense RNA
1.4 Market Segment by Application
1.4.1 Global Antisense and RNAi Therapeutics Market Share by Application (2020-2025)
1.4.2 Hospital
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Antisense and RNAi Therapeutics Production Value 2015-2025
2.1.2 Global Antisense and RNAi Therapeutics Production 2015-2025
2.1.3 Global Antisense and RNAi Therapeutics Capacity 2015-2025
2.1.4 Global Antisense and RNAi Therapeutics Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Antisense and RNAi Therapeutics Market Size CAGR of Key Regions
2.2.2 Global Antisense and RNAi Therapeutics Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Antisense and RNAi Therapeutics Capacity by Manufacturers
3.1.2 Global Antisense and RNAi Therapeutics Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Antisense and RNAi Therapeutics Revenue by Manufacturers (2015-2019)
3.2.2 Antisense and RNAi Therapeutics Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Antisense and RNAi Therapeutics Market Concentration Ratio (CR5 and HHI)
3.3 Antisense and RNAi Therapeutics Price by Manufacturers
3.4 Key Manufacturers Antisense and RNAi Therapeutics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antisense and RNAi Therapeutics Market
3.6 Key Manufacturers Antisense and RNAi Therapeutics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 RNA Interference Production and Production Value (2015-2019)
4.1.2 Antisense RNA Production and Production Value (2015-2019)
4.2 Global Antisense and RNAi Therapeutics Production Market Share by Type
4.3 Global Antisense and RNAi Therapeutics Production Value Market Share by Type
4.4 Antisense and RNAi Therapeutics Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antisense and RNAi Therapeutics Consumption by Application
6 Production by Regions
6.1 Global Antisense and RNAi Therapeutics Production (History Data) by Regions 2015-2019
6.2 Global Antisense and RNAi Therapeutics Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Antisense and RNAi Therapeutics Production Growth Rate 2015-2019
6.3.2 United States Antisense and RNAi Therapeutics Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Antisense and RNAi Therapeutics Import & Export
6.4 European Union
6.4.1 European Union Antisense and RNAi Therapeutics Production Growth Rate 2015-2019
6.4.2 European Union Antisense and RNAi Therapeutics Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Antisense and RNAi Therapeutics Import & Export
6.5 China
6.5.1 China Antisense and RNAi Therapeutics Production Growth Rate 2015-2019
6.5.2 China Antisense and RNAi Therapeutics Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Antisense and RNAi Therapeutics Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Antisense and RNAi Therapeutics Consumption by Regions
7.1 Global Antisense and RNAi Therapeutics Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Antisense and RNAi Therapeutics Consumption by Type
7.2.2 United States Antisense and RNAi Therapeutics Consumption by Application
7.3 European Union
7.3.1 European Union Antisense and RNAi Therapeutics Consumption by Type
7.3.2 European Union Antisense and RNAi Therapeutics Consumption by Application
7.4 China
7.4.1 China Antisense and RNAi Therapeutics Consumption by Type
7.4.2 China Antisense and RNAi Therapeutics Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Antisense and RNAi Therapeutics Consumption by Type
7.5.2 Rest of World Antisense and RNAi Therapeutics Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Tekmira Pharmaceuticals
8.1.1 Tekmira Pharmaceuticals Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Antisense and RNAi Therapeutics
8.1.4 Antisense and RNAi Therapeutics Product Introduction
8.1.5 Tekmira Pharmaceuticals Recent Development
8.2 Arbutus Biopharma
8.2.1 Arbutus Biopharma Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Antisense and RNAi Therapeutics
8.2.4 Antisense and RNAi Therapeutics Product Introduction
8.2.5 Arbutus Biopharma Recent Development
8.3 Alnylam Pharmaceuticals
8.3.1 Alnylam Pharmaceuticals Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Antisense and RNAi Therapeutics
8.3.4 Antisense and RNAi Therapeutics Product Introduction
8.3.5 Alnylam Pharmaceuticals Recent Development
8.4 Antisense Therapeutics
8.4.1 Antisense Therapeutics Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Antisense and RNAi Therapeutics
8.4.4 Antisense and RNAi Therapeutics Product Introduction
8.4.5 Antisense Therapeutics Recent Development
8.5 Silence Therapeutics
8.5.1 Silence Therapeutics Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Antisense and RNAi Therapeutics
8.5.4 Antisense and RNAi Therapeutics Product Introduction
8.5.5 Silence Therapeutics Recent Development
8.6 Isis Pharmaceuticals
8.6.1 Isis Pharmaceuticals Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Antisense and RNAi Therapeutics
8.6.4 Antisense and RNAi Therapeutics Product Introduction
8.6.5 Isis Pharmaceuticals Recent Development
8.7 Sirnaomics
8.7.1 Sirnaomics Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Antisense and RNAi Therapeutics
8.7.4 Antisense and RNAi Therapeutics Product Introduction
8.7.5 Sirnaomics Recent Development
8.8 Santaris
8.8.1 Santaris Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Antisense and RNAi Therapeutics
8.8.4 Antisense and RNAi Therapeutics Product Introduction
8.8.5 Santaris Recent Development
8.9 Roche
8.9.1 Roche Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Antisense and RNAi Therapeutics
8.9.4 Antisense and RNAi Therapeutics Product Introduction
8.9.5 Roche Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Antisense and RNAi Therapeutics Capacity, Production Forecast 2020-2025
9.1.2 Global Antisense and RNAi Therapeutics Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Antisense and RNAi Therapeutics Production and Value Forecast by Regions 2020-2025
9.2.2 Global Antisense and RNAi Therapeutics Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Antisense and RNAi Therapeutics Production Forecast by Type
9.7.2 Global Antisense and RNAi Therapeutics Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Antisense and RNAi Therapeutics Sales Channels
10.2.2 Antisense and RNAi Therapeutics Distributors
10.3 Antisense and RNAi Therapeutics Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter\'s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
